XIGDUO XR TABLETS 5MG/500MG
Product details
Registration number: SIN15077P
Classification: Prescription Only
Active ingredients:
- Dapagliflozin propanediol 6.15mg eqv Dapagliflozin
- Metformin 390mg eqv to Metformin hydrochloride
Strength:
- 5mg
- 500mg
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Registrant: ASTRAZENECA SINGAPORE PTE LTD
ATC code: A10BD15
HSA approval date: 30 August 2016
Manufacturer(s):
- AstraZeneca Pharmaceuticals LP
- Merck Sante (Drug Product Intermediate - Metformin)
- Merck Sante S.A.S. (Drug Product Intermediate – Metformin)
Manufacturing country/countries: UNITED STATES; FRANCE
What are the HSA registration number and classification for XIGDUO XR TABLETS 5MG/500MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15077P
Classification: Prescription Only
What active ingredients and strength are recorded for XIGDUO XR TABLETS 5MG/500MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Dapagliflozin propanediol 6.15mg eqv Dapagliflozin
- Metformin 390mg eqv to Metformin hydrochloride
Strength:
- 5mg
- 500mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for XIGDUO XR TABLETS 5MG/500MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Who is the recorded registrant for XIGDUO XR TABLETS 5MG/500MG?
According to the HSA dataset updated 7 August 2026:
Registrant: ASTRAZENECA SINGAPORE PTE LTD
Which manufacturers and countries are listed for XIGDUO XR TABLETS 5MG/500MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- AstraZeneca Pharmaceuticals LP
- Merck Sante (Drug Product Intermediate - Metformin)
- Merck Sante S.A.S. (Drug Product Intermediate – Metformin)
Manufacturing country/countries: UNITED STATES; FRANCE
Where can I look up XIGDUO XR TABLETS 5MG/500MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15077P or the exact product name XIGDUO XR TABLETS 5MG/500MG. The general register link does not preselect this product.
What are the source dates for this XIGDUO XR TABLETS 5MG/500MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this XIGDUO XR TABLETS 5MG/500MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15077P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)